BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33461100)

  • 21. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study.
    Jensen AB; Larsen M; Gislum M; Skriver MV; Jepsen P; Nørgaard B; Sørensen HT
    Am J Gastroenterol; 2006 Jun; 101(6):1283-7. PubMed ID: 16771950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort.
    Matsuoka H; Ikeuchi H; Uchino M; Bando T; Takesue Y; Nishigami T; Tomita N
    Int J Colorectal Dis; 2013 Jun; 28(6):829-34. PubMed ID: 23080343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological differentiation between sporadic and colitis-associated intestinal cancer in a nationwide study: A propensity-score-matched analysis.
    Uchino M; Ikeuchi H; Noguchi T; Okabayashi K; Futami K; Tanaka S; Ohge H; Watanabe K; Itabashi M; Okamoto K; Okita Y; Mizushima T; Mizuuchi Y; Yamada K; Shimada Y; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Hanai T; Kono T; Kobayashi H; Ajioka Y; Sugihara K; Ishihara S;
    J Gastroenterol Hepatol; 2024 May; 39(5):893-901. PubMed ID: 38273469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of CA2 and CA9 carbonic anhydrases in ulcerative colitis and ulcerative colitis-associated colorectal cancer.
    Nakada N; Mikami T; Horie K; Nagashio R; Sakurai Y; Sanoyama I; Yoshida T; Sada M; Kobayashi K; Sato Y; Okayasu I; Murakumo Y
    Pathol Int; 2020 Aug; 70(8):523-532. PubMed ID: 32410301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical Expression of CD133 and LGR5 in Ulcerative Colitis-associated Colorectal Cancer and Dysplasia.
    Kazama S; Kishikawa J; Tanaka T; Hata K; Kawai K; Nozawa H; Ishihara S
    In Vivo; 2019; 33(4):1279-1284. PubMed ID: 31280219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan.
    Fujita T; Ando T; Watanabe O; Hasegawa M; Miyake N; Kondo S; Kato T; Ishiguro K; Nakamura M; Miyahara R; Ohmiya N; Niwa Y; Goto H
    Hepatogastroenterology; 2010; 57(99-100):487-92. PubMed ID: 20698214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
    Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.
    Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Lancet; 2020 Jan; 395(10218):123-131. PubMed ID: 31929014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant methylation of PSD disturbs Rac1-mediated immune responses governing neutrophil chemotaxis and apoptosis in ulcerative colitis-associated carcinogenesis.
    Kato T; Suzuki K; Okada S; Kamiyama H; Maeda T; Saito M; Koizumi K; Miyaki Y; Konishi F
    Int J Oncol; 2012 Apr; 40(4):942-50. PubMed ID: 22179719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study.
    Lakatos L; Mester G; Erdelyi Z; David G; Pandur T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Inflamm Bowel Dis; 2006 Mar; 12(3):205-11. PubMed ID: 16534422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer.
    Zhang C; Zhang J; Zhang Y; Song Z; Bian J; Yi H; Ma Z
    Front Immunol; 2023; 14():1095098. PubMed ID: 36845139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Lysophospholipid Components in Ulcerative Colitis and Colitis-associated Cancer.
    Sonoda H; Kitamura C; Kano K; Anzai H; Nagai Y; Abe S; Yokoyama Y; Ishii H; Kishikawa J; Murono K; Emoto S; Sasaki K; Kawai K; Nozawa H; Aoki J; Ishihara S
    Anticancer Res; 2022 May; 42(5):2461-2468. PubMed ID: 35489747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases.
    Hata K; Anzai H; Ikeuchi H; Futami K; Fukushima K; Sugita A; Uchino M; Higashi D; Itabashi M; Watanabe K; Koganei K; Araki T; Kimura H; Mizushima T; Ueda T; Ishihara S; Suzuki Y;
    Am J Gastroenterol; 2019 Mar; 114(3):483-489. PubMed ID: 30747769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum type XVI collagen is associated with colorectal cancer and ulcerative colitis indicating a pathological role in gastrointestinal disorders.
    Jensen C; Nielsen SH; Mortensen JH; Kjeldsen J; Klinge LG; Krag A; Harling H; Jørgensen LN; Karsdal MA; Willumsen N
    Cancer Med; 2018 Sep; 7(9):4619-4626. PubMed ID: 30030909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Pekow J; Hutchison AL; Meckel K; Harrington K; Deng Z; Talasila N; Rubin DT; Hanauer SB; Hurst R; Umanskiy K; Fichera A; Hart J; Dinner AR; Bissonnette M
    Inflamm Bowel Dis; 2017 Aug; 23(8):1328-1337. PubMed ID: 28594651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis.
    Demir AK; Demirtas A; Kaya SU; Tastan I; Butun I; Sagcan M; Sahin S; Tasliyurt T; Yilmaz A
    Kaohsiung J Med Sci; 2015 Nov; 31(11):585-90. PubMed ID: 26678939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.